Submitted manuscript of a guidance document outlining standards for conducting medication utilisation studies in pregnant women data collection and analytic standards for established and newly marketed products (D1.5)
sue jordan(Swansea University), Amanda J. Neville(University of Ferrara), Julie Scotto(Bristol-Myers Squibb (United States)), Jingping Mo(Pfizer (United States)), Xuân Anh Phí, Sandra Lopez Leon(Novartis (United States)), Keele Wurst(GlaxoSmithKline (United States)), Meritxell Sabidó, Anja Geldhof, Ditte Mølgaar-Neislen(Statens Serum Institut), Jorieke E. H. Bergman(University Medical Center Groningen)
Cited by 0
Related Papers
Long term trends in prevalence of neural tube defects in Europe: population based study
|BMJ|2015|247
Associated anomalies in multi‐malformed infants with cleft lip and palate: An epidemiologic study of nearly 6 million births in 23 EUROCAT registries
|American Journal of Medical Genetics Part A|2007|243
Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data
|Archives of Disease in Childhood Fetal & Neonatal|2017|224
Trends in congenital anomalies in Europe from 1980 to 2012
|PLoS ONE|2018|165
Epidemiology of hypospadias in Europe: a registry-based study
|World Journal of Urology|2015|137